Global Superabsorbent Polymers Market

Diagnostic enzymes refer to the enzymes that are employed directly or as part of an assay system to determine the presence or absence of a variety of compounds, and they are used to detect, diagnose, or predict the development of disease conditions. These enzymes are used in diagnosis because of their substrate selectivity and quantified activity when other proteins are present. The main types of products in diagnostic enzymes are carbohydrates, polymerases, nucleases, proteases, and others. Any of a class of enzymes (such as amylase) that promotes carbohydrate breakdown or synthesis is referred to as a carbohydrase (such as a disaccharide). The different sources include animals, microorganisms, and plants and are used in biocatalysts, diagnostics, pharmaceuticals, research, and biotechnology. The diagnostic enzymes market research report is one of a series of new reports from The Business Research Company that provides diagnostic enzymes market statistics, including global market size, regional shares, competitors with a diagnostic enzymes market share, detailed diagnostic enzymes market segments, market trends and opportunities, and any further data you may need to thrive in the diagnostic enzymes industry. This diagnostic enzymes market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry. The global diagnostic enzymes market grew from $3.8 billion in 2022 to $4.02 billion in 2023 at a compound annual growth rate (CAGR) of 5.7%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The diagnostic enzymes market is expected to grow from $5.1 billion in 2027 at a CAGR of 6.1%. The rise in the geriatric population, which increases the patient pool for the diagnosis of chronic diseases, contributed to the growth of the diagnostic enzymes market. The proportion of people above the age of 65 increased globally, and age-related chronic ailments also increased. For example, the percentage of seniors is expected to grow from 28% in 2019 to 38% by 2050 in Japan. The increase in the ageing population has increased the patient pool of many chronic diseases such as rheumatoid arthritis, hypertension, diabetes, and cancer. People suffering from these diseases are expected to be more vulnerable to chronic diseases, thus significantly influencing market growth during this period. According to the World Population Ageing report, there were 727 million people over the age of 65 in 2020, accounting for 9.3% of the global population, and this figure is expected to rise to around 16.0% by 2050.According to the World Health Organization report for 2021, approximately 10 million cancer-related deaths occurred in 2020. Thus, the rise in the geriatric population increases the number of patients for the diagnosis of chronic diseases, which, in turn, drives the diagnostic enzymes market. The high sensitivity of enzymes to temperature and pH levels is expected to limit the diagnostic enzymes market. Enzymes need to be stored at optimum temperatures and are generally stored at -20 degrees Celsius. According to the Worthington Biochemical Corporation, variations in the reaction by one or two degrees in temperature may have a change of 10 to 20% in the result. In enzymatic reactions, this is complicated as enzymes are adversely affected by high temperatures, and are expected to be deactivated at even moderate temperatures. Enzymes are affected by changes in pH, as pH is also a factor in the stability of the enzymes. The changes in temperature and pH levels may decrease the efficiency of the diagnostic enzymes, which, in turn, hampers the growth of the diagnostic enzymes market. The use of machine learning and artificial intelligence is gradually gaining popularity in the enzyme diagnostic market. Artificial intelligence (AI) is the simulation of human intelligence in machines and is programmed to display their natural intelligence. Machine learning is a part of AI. Machine learning and AI help companies in the enzyme diagnostic market to conduct a detailed analysis of all relevant data, provide insights into the function of enzymes, and allow physicians to understand the key determinants of the relationship between protein structure, function, and evolution, in terms of the catalysis of the reaction steps of an enzyme. For instance, companies such as BioMarker have invested in AI and machine learning for enzyme diagnostics. In June 2020, Codexis, Inc., a US-based protein engineering company and developer of high-performance enzymes, and Alphazyme LLC., a US-based company in the development and manufacture of nucleic acid metabolising enzymes, announced a co-marketing enzyme supply collaboration agreement for the production and co-marketing of enzymes for life science applications, including diagnostics. This collaboration is expected to leverage the experience and industry knowledge of Alphazyme to accelerate the market introduction of Codexis’ portfolio of high-performing life science and diagnostic enzymes while providing Alphazyme with exclusive manufacturing and co-marketing rights to CodeEvolver-improved enzymes. This partnership will allow both companies to jointly promote and sell these enzymes to innovators in life science and diagnostic markets. Major players in the diagnostic enzymes market are Genzyme, Roche, Codexis, Aldevron, Kaneka Eurogentec, Vigene Biosciences, Amano Enzymes, Advanced Enzymes Technologies, Thermo Fisher Scientific, and EKF Diagnostic. North America was the largest region in the enzymes market in 2022. The Middle East is expected to be the fastest-growing region in the global diagnostic enzyme market during the forecast period. The regions covered in the global diagnostic enzymes market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the diagnostic enzymes market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The diagnostic enzymes market consists of sales of acid phosphatase, alanine aminotransferase, cholinesterase, and aspartate aminotransferase. Values in this market are "factory gate values," that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organisations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the chain or as part of other products. The global diagnostic enzyme market is segmented - 1) By Product Type: Carbohydrases, Polymerases And Nucleases, Protease, and Other Product Types 2) By Source: Animals, Microorganisms, and Plants 3) By Application: Biocatalysts, Diagnostics, Pharmaceuticals, Research, and Biotechnology

Polymer biomaterials are inert pharmacological substances made up of natural and synthetic origin. The polymer biomaterials are used for enhancing the functionality of tissues and organs that are damaged in various disease therapies. The main types in the polymer biomaterial are silicone rubber, polyester, polymethyl methacrylate (PMMA), polyethylene (PE), polyvinyl chloride, and others. The silicon rubber in polymer biomaterials refers to the rubber matrix that is lightly cross-linked with a polyacrylamide hydrogel and is used for biological and medical purposes. The various nature includes natural and synthetic. The polymer biomaterials are used in cardiovascular, ophthalmology, dental, plastic surgery, wound healing, tissue engineering, orthopedics, neurological disorders / central nervous systems, and others. The polymer biomaterial market research report is one of a series of new reports from The Business Research Company that provides polymer biomaterial market statistics, including polymer biomaterial industry global market size, regional shares, competitors with a polymer biomaterial market share, detailed polymer biomaterial market segments, market trends and opportunities, and any further data you may need to thrive in the polymer biomaterial industry. This polymer biomaterial market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global polymer biomaterial market grew from $55.96 billion in 2022 to $66.45 billion in 2023 at a compound annual growth rate (CAGR) of 18.7%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The polymer biomaterial market is expected to grow from $126.74 billion in 2027 at a CAGR of 17.5%. Increasing applications of polymeric biomaterials in tissue engineering are driving the global polymer biomaterials market. Polymers are extensively used in regenerative medicine and tissue engineering due to their flexibility and versatile properties such as tailoring the damaged tissue's physical, chemical, and mechanical properties by modification of functional groups during synthesis, according to the regeneration capability of tissues of the organs. Besides being biodegradable, they offer different geometry and structures, thus meeting the needs of specific tissue engineering applications. These growing applications of polymer biomaterial in tissue engineering are expected to drive the market in the forecast period. Stringent regulatory systems concerning the biocompatibility of polymer biomaterials are expected to limit the global polymer biomaterials market. Although biomaterials undergo rigorous premarket evaluations, considerable adverse events and complications are reported regarding the biocompatibility of polymer biomaterials. Biomaterial implantation may result in immunological and inflammatory reactions due to the induction of cellular and molecular events in the host, which may lead to excessive inflammation, impairment of healing, fibrotic encapsulation, tissue destruction, or even isolation and rejection of the implant. To overcome such adverse immune reactions, stringent regulations are imposed by the regulatory authorities, restricting the market growth. Companies in the polymer biomaterial market are increasingly investing in bioresorbable copolymers for medical devices for better performance and long-term stability. Companies such as Evonik have invested in bioresorbable polymers for use in implantable medical devices. The company's copolymer possesses hydrophobic properties of polylactide and hydrophilic properties of polyethylene glycol enabling the degradation rates up to six times faster with added mechanical strength. This innovation enhances biocompatibility, safety, and performance of implantable products, and is applied in the areas of pediatrics and wound closure to accelerate and ease the healing process and provide long-term stability. In January 2020, Mitsubishi Chemical Corporation completed the acquisition of AdvanSource Biomaterials Corporation for $7.25 million. This acquisition is expected to strengthen Mitsubishi’s position within the medical sector and drive its revenues. AdvanSource Biomaterials is a US-based company that manufactures polymer materials that provide critical characteristics in the design and development of medical devices. These polymer biomaterials are used in devices that are designed for treating a broad range of anatomical sites and disease states. Major players in the polymer biomaterials market are BASF, Corbion, Zimmer Biomet, Royal DSM, Koninklijke DSM, Covestro, Evonik Industries, Starch Medical, Victrex, and W. L. Gore and Associate. North America was the largest region in the polymer biomaterials market in 2022. Western Europe was the second largest region in the global polymer biomaterials market report. The regions covered in global polymer biomaterial market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the polymer biomaterials market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and USA. The polymer biomaterials market consists of sales of PCL, PVDF, PLGA, PVP, and nylon. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global polymer biomaterial market is segmented - 1) By Type: Nylon, Silicone Rubber, Polyester, Polymethyl Methacrylate (PMMA), Polyethylene (PE), Polyvinyl Chloride, Other Types 2) By Application: Cardiovascular, Ophthalmology, Dental, Plastic Surgery, Wound Healing, Tissue Engineering, Orthopedics, Neurological Disorders / Central Nervous System, Other Applications 3) By Nature: Natural, Synthetic

The petrochemicals refer to distinct chemicals made from refined petroleum or liquid hydrocarbons that are used for commercial purposes. The petrochemicals are also made from other fossil fuels, such as coal, natural gas, and renewable sources such as maize, sugar cane, or palm fruit. The main types of petrochemicals are ethylene-petrochemicals, propylene-petrochemicals, benzene-petrochemicals, xylene, styrene-petrochemicals, toluene, cumene, and other types of petrochemicals. Xylene is an aromatic hydrocarbon existing in three isomeric forms, all three being colorless flammable volatile liquids used as solvents and for the manufacturing of synthetic resins, dyes, and insecticides such as dimethylbenzene. The applications are polymers, paints and coatings, solvents, rubber, adhesives and sealants, surfactants, pigments and dyes, fibers and fabrics, and other applications. The end-user industries are construction, packaging, automotive and transportation, healthcare, electrical and electronics, and other end-user industries. The petrochemicals market research report is one of a series of new reports from The Business Research Company that provides petrochemicals market statistics, including petrochemicals industry global market size, regional shares, competitors with a petrochemicals market share, detailed petrochemicals market segments, market trends and opportunities, and any further data you may need to thrive in the petrochemicals industry. This petrochemicals market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global petrochemicals market grew from $671.57 billion in 2022 to $693.3 billion in 2023 at a compound annual growth rate (CAGR) of 3.2%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The petrochemicals market is expected to grow to $786.74 billion in 2027 at a CAGR of 3.2%. The petrochemicals market is expected to benefit from growth in the automobile industry during the forecast period. There is a drive for the production of automobiles, which is leading to an increase in demand for petrochemical products that are used in the manufacturing of brake parts, radiators, and other components. For instance, according to an estimation by Goldman Sachs, a US-based investment banking company, the global sales of new cars in emerging markets is expected to increase from 68 million in 2020 to 78 million by 2025. Thus, the growth of automobiles is expected to increase the demand for petrochemicals during the forecast period. Oil price volatility is likely to have a negative impact on the petrochemicals market as significant declines and increases in oil prices negatively impact government and consumer spending. The decline in oil prices is having a negative impact on government spending in countries such as Saudi Arabia, Nigeria, and the UAE (United Arab Emirates), which are largely dependent on revenues generated through crude oil exports, whereas a significant increase in oil prices has resulted in a spurt in inflation, current account deficit, and fiscal deficit in countries such as India and China, which predominantly import oil. For instance, the Saudi government is expected to cut down its spending from 1.05 trillion riyals ($280 billion) in 2019 to 1.02 trillion riyals ($270 billion) in 2020 and to 955 billion riyals ($255 billion) by 2022 due to a significant decline in revenues generated from oil exports, thereby affecting the market. This high volatility in the oil process is further expected to negatively impact the market going forward. Many petrochemical manufacturers are adopting IoT (Internet of Things) technologies to connect equipment and smart devices to obtain real-time insights and identify inefficiencies in the manufacturing process. The data obtained is processed, analyzed, and interpreted by plant managers and senior-level management to improve quality and achieve optimum production levels. For example, smart systems give information on the working condition and performance of chemical reactors with embedded software and analytics tools to notify plant operators and managers of possible machine breakdowns. Major companies in the petrochemicals market include JXTG Holdings Inc., Saudi Basic Industries Corporation (SABIC), Sinopec Limited, Royal Dutch Shell, Reliance Industries Limited, LG Chem Ltd., Guardian Industries LLC, Odebrecht Engenharia E Construcao Sa, Mitsubishi Chemical Holdings Corp, and BASF SE. Asia-Pacific was the largest region in the petrochemicals market in 2022. Middle East was the second largest region in the petrochemicals market. The regions covered in the petrochemicals report market are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the petrochemicals market are Argentina, Australia, Austria, Bangladesh, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Iran, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, Ukraine, USA, and Vietnam. The petrochemicals market consists of the sales of aliphatic compounds, aromatic compounds, inorganic compounds, and synthesis gas. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global petrochemicals market is segmented - 1) By Type: Ethylene-Petrochemicals, Propylene-Petrochemicals, Benzene-Petrochemicals, Xylene, Styrene-Petrochemicals, Toluene, Cumene, Other Petrochemicals 2) By Application: Polymers, Paints & Coatings, Solvents, Rubber, Adhesives & Sealants, Surfactants, Pigments & Dyes, Fibers & Fabrics, Other Applications 3) By End Userr Industry: Construction, Packaging, Automotive & Transportation, Healthcare, Electrical & Electronics, Other End-User Industries

Propylene petrochemical is a basic versatile chemical as ethylene used in the manufacture of common household items. Propylene is a component of the addition polymer poly (propane), and it is also used in the production of epoxy propane and propanol. The main types of propylene petrochemicals are homopolymers and copolymers. A homopolymer is a polymer like polyethylene consisting of identical monomer units. The various applications are injection molding, fiber and raffia, film and sheet, and blow molding. The end-user industries are automotive, construction, packaging, textiles, and other end-user industries. The propylene-petrochemical market research report is one of a series of new reports from The Business Research Company that provides propylene-petrochemical market statistics, including propylene-petrochemical industry global market size, regional shares, competitors with a propylene-petrochemical market share, detailed propylene-petrochemical market segments, market trends and opportunities, and any further data you may need to thrive in the propylene-petrochemical industry. This propylene-petrochemical market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global propylene-petrochemicals market size will grow from $104.04 billion in 2022 to $107.4 billion in 2023 at a compound annual growth rate (CAGR) of 3.2%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global propylene-petrochemicals market size is expected to grow from $121.74 billion in 2027 at a CAGR of 3.2%. The propylene market is expected to benefit from growth in the automobile industry during the forecast period. Polypropylene is a polymer produced from the propylene monomer which is used in the automobile industry. Large-scale production of automobiles is leading to an increase in demand for polypropylene products, which are used in the manufacturing of battery cases and trays, bumpers, interior trim, instrument panels, fender liners, door trims, and other components. For instance, according to an estimation by Goldman Sachs, a US-based investment banking company, the global sales of new cars in emerging markets is expected to increase from 68 million in 2020 to 78 million by 2025. Thus, increased use of plastics in automobiles is expected to increase the demand for propylene during the forecast period. Stringent safety regulations associated with the manufacture and transportation of propylene were a significant market restraint. Propylene is highly inflammable, toxic, and hazardous when exposed to extreme temperatures and pressures. Propylene suppliers should invest in equipment, technologies, and processes to limit the toxic levels and chemical concentrations. These regulations increased the operating costs of companies in the propylene industry, thus limiting the scope for investments relating to the launch of new products and expansion into new markets, thereby affecting the market growth. Petrochemical companies are adopting on-purpose propylene production technologies to produce propylene as a sole product but not as an alternate or co-product. On-purpose propylene technology refers to a modified version of the traditional fluid catalytic cracking unit which increases propylene yield by 20% more than the actual output. Traditional sources for propylene, which include steam crackers and oil refineries, yield fewer propylene as a derivative or co-product due to a shift in feedstocks from naphtha to ethane. To meet the increased demand for propylene, petrochemical companies are investing in developing on-purpose technologies to accelerate the shortfall in propylene production. Major on-purpose technologies include propane dehydrogenation, methanol-to-olefins/methanol-to-propylene (MTO/MTP), high-severity fluidized catalytic cracking (HS-FCC), coal-to-olefins/coal-to-propylene (CTO/CTP), and gas-to-olefins (GTO). For Instance, major companies adopting this technology include, BASF, Dow Chemical, ExxonMobil Chemical, and Sidi Kerir Petrochemicals Co (SIDPEC). In January 2022, Invista, a US-based fiber, resin and intermediates company acquired propylene business of Flint Hills Resources for an undisclosed amount. The acquisition includes chemical facilities in Houston and Longview, Texas, ownership of pipelines that supply facilities, and support employees. The The transaction expanded Invista's portfolio and allowed for future growth. Flint Hills Resources is an American refining company. Major players in the propylene-petrochemicals market are AGC Chemicals, Archer Daniels Midland Company, Asahi Kasei Corporation, BASF SE, Chevron Phillips Chemical Company, China National Petroleum Corp. (CNPC), China Petrochemical Corporation, Dangote Industries Ltd., Eni SpA, Enterprise Products Partners L.P., and Exxon Mobil Corporation. Asia-Pacific was the largest region in the propylene-petrochemical market in 2022. Middle East was the second-largest region in the global propylene-petrochemicals market. The regions covered in the global propylene-petrochemical report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the propylene-petrochemicals market are Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, the UK, the USA, and Australia. The propylene petrochemical market consists of the sales of propylene petrochemicals used in the production of acrylics, rubbing alcohol, epoxy glue, and carpets. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global propylene-petrochemicals market is segmented - 1) By Type: Homopolymer, Copolymer 2) By Application: Injection Molding, Fiber & Raffia, Film & Sheet, Blow Molding 3) By End User Industry: Automotive, Construction, Packaging, Textile, Other End-Use Industries

Activated carbon is used to purify gases and liquids in a variety of applications such as municipal drinking water, industrial pollution control, food and beverage processing, and odor removal. It also helps in de-colorization and solvent purification in industrial sectors such as chemical, petrochemical, mining, and automotive. Activated carbon is produced from carbonaceous sources such as nutshells, coal, coconut, wood, and peat. The main types of activated carbons are powdered activated carbon, polymer coated activated carbon, granular activated carbon, bead activated carbon, extruded or pelletized activated carbon, others. Powder activated carbon (PAC) or pulverized activated carbon is small activated carbon particle produced by pulverizing or milling activated carbon. Granular activated carbon is made from organic materials like coconut shells or coal having high carbon concentration and is used in both liquid and gas phase applications. Bead activated carbon is made from petroleum pitch and has wide-ranging uses, including air deodorizing, gas adsorption and water purification. Extruded or pelletized activated carbon is made by mixing pulverized anthracite or charcoal with a suitable binder and then extruded at high pressure into a cylindrical shaped form and are used for gas phase applications. The activated carbon is used for liquid phase applications, gas phase applications, metal extraction, medicine, others and is applied in various areas including water treatment, food & beverage processing, pharmaceutical & medical, automotive and air purification. The activated carbon market research report is one of a series of new reports from The Business Research Company that provides activated carbon market statistics, including activated carbon industry global market size, regional shares, competitors with a activated carbon market share, detailed activated carbon market segments, market trends and opportunities, and any further data you may need to thrive in the activated carbon industry. This activated carbon market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global activated carbon market size grew from $5.45 billion in 2022 to $6.21 billion in 2023 at a compound annual growth rate (CAGR) of 13.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services, and affecting many markets across the globe. The activated carbon market size is expected to grow to $10.29 billion in 2027 at a CAGR of 13.5%. The growing demand for clean water is expected to drive the growth of the activated carbon market. Rapid urbanization and industrialization is surging demand for clean water and activated carbon, as activated carbon is a key ingredient in water purification. According to the United Nations World Water Development Report, nearly 6 billion people are expected to suffer from lack of clean water by 2050. Therefore, the increasing need for clean water and clean water scarcity is expected to generate high demand for the activated carbon for water purification in the forecast period. Price fluctuation in raw materials is anticipated to restrain the market for activated carbon in the forecast period. The shortage of raw materials such as coconut shell charcoal leads to an increase in raw material costs, resulting in higher manufacturing costs. The increasing costs of some grades of activated carbon would act as a restraint for the market in the forecast period. Strategic initiatives such as technological advancements and innovative product development are gaining significant popularity in the activated carbon market. The companies are increasingly focusing on developing new innovative products such as honeycomb activated carbon which is environmentally friendly and is designed to be powerful and flexible for large area purification. Honeycomb-activated carbon is a highly effective carbon that is used to remove unpleasant odors and pollutant particles. For instance, in January 2021, Tantech, a China-based company launched a variety of combination honeycomb activated carbon. Other innovative products include activated carbon masks by Sweden based Jacobi Carbon, for clear air delivery. The mask uses activated carbon in combination with dust aerosol and other particulate matter filtration systems for cleaning the air and can also be used as a mask. In October 2020, Brenntag SE, a Germany-based chemical and ingredients distribution company signed an agreement to acquire Comelt S.p.A and its subsidiary Aquadepur S.R.L. for an undisclosed amount. With the acquisition of Comelt S.p.A., Brenntag plans to expand the local and international business for activated carbon. Moreover, the acquisition of Comelt S.p.A is expected to help the company better assist customers with meeting their sustainability objectives. Comelt S.p.A is an Italy-based company engaged in processing, marketing, and distribution of activated and re-activated carbon for various applications such as water purification and filtration of the flue and air gas. Major players in the activated carbon market are Calgon Carbon Corporation, Haycarb PLC, Kureha Corporation, Donau Carbon GmbH, Silcarbon Aktivkohle GmbH, Puragen LLC, Universal Carbons, Adsorbent Carbons, Shinkwang Chem Ind Co Ltd., Century Chemical Works Sdn Bhd, Kalimati Carbon Pvt Ltd., Puragen LLC, Universal Carbons, Oxbow Coal SARL, Adsorbent Carbon Private Ltd., Sunny Earth Minerals Ltd., Capital Carbon, and EcoGreen Technological. Asia-Pacific was the largest region in the activated carbon market in 2022. North America was the second largest market in activated carbon market. The regions covered in the activated carbon market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the activated carbon market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The activated carbon market consists of sales of catalytic activated carbon and impregnated activated carbon. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global activated carbon market is segmented - 1) By Type: Powdered Activated Carbon, Polymer Coated Activated Carbon, Granular Activated Carbon, Bead Activated Carbon, Extruded or Pelletized Activated Carbon, Other Types 2) By Application: Liquid Phase Applications, Gas Phase Applications, Metal Extraction, Medicine, Other Applications 3) By End Use: Water Treatment, Food & Beverage Processing, Pharmaceutical & Medical, Automotive, Air Purification, Other End Uses

Anti-viral drug therapy refers to drugs that are used for the treatment of viral infections, such as human immunodeficiency virus (HIV), hepatitis, influenza, and novel coronavirus. Antiviral drugs do not kill their target pathogens; instead, they inhibit the development of those viruses. The anti-viral drug establishments are primarily engaged in the manufacturing of DNA polymerase inhibitors, reverse transcriptase inhibitors, protease inhibitors, neuraminidase inhibitors, and others. The main types of anti-viral drug therapy are branded and generic. The various drug classes involved are DNA polymerase inhibitors, reverse transcriptase inhibitors, protease inhibitors, neuraminidase inhibitors, and others that are used for HIV, hepatitis, herpes, influenza, and others. Reverse-transcriptase inhibitors (RTIs) are a type of antiretroviral medication used to treat HIV infection or AIDS, as well as hepatitis B in some cases. The anti-viral drug therapy market research report is one of a series of new reports from The Business Research Company that provides anti-viral drug therapy market statistics, including anti-viral drug therapy industry global market size, regional shares, competitors with an anti-viral drug therapy market share, detailed anti-viral drug therapy market segments, market trends and opportunities, and any further data you may need to thrive in the anti-viral drug therapy industry. This anti-viral drug therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global antivirals market size will grow from $97.14 billion in 2022 to $107.84 billion in 2023 at a compound annual growth rate (CAGR) of 11.0%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global antivirals market size is expected to grow to $156.99 billion in 2027 at a CAGR of 9.8%. The demand for anti-viral drugs is anticipated to grow at a rapid pace due to the novel coronavirus outbreak. As there are no vaccines and potential treatments for COVID-19, companies are trying to repurpose existing drugs in the fight against the novel coronavirus. The use of certain existing anti-viral drugs for the COVID-19 treatment is contributing to the growth of the anti-viral drugs market. However, if any of these drugs under trial show further promising results in treating the coronavirus infection, the anti-viral market will see further growth. Increasing public-private funding for life science research globally is expected to drive the growth of the anti-viral drug therapy market. Currently, there are no drugs or vaccines approved for the treatment of COVID-19 disease, however, there are several vaccines and drugs in the pipeline, that are yet to be approved or launched. Governments around the world announced new grant funds for researchers in vaccines, treatment, and diagnostics. In March 2020, the Canadian government announced $214.6 million for coronavirus research. Wellcome and the Gates Foundation announced they are joining forces with the credit card company MasterCard in a $125 million push to speed up the development of drugs for treating COVID-19 infections. Hence increasing public-private funding for life science research will enhance the research and development which drive the growth of the COVID-19 anti-viral drug therapy market. The emergence of alternative therapies such as naturopathy and homeopathy for the treatment of viral infections is negatively affecting the market. The development of COVID-19 anti-viral drugs involves high R&D costs. The development of COVID-19 anti-viral drugs involves high operating costs and requires a greater capital investment. Due to the high R&D costs involved in drug development, there is a growth in the demand for alternative medicines such as naturopathy and homeopathy. Saikosaponins (A, B2, C, and D), which are naturally occurring triterpene glycosides isolated from medicinal plants such as Bupleurum spp., Heteromorpha spp., and Scrophulariascorodonia, exert antiviral activity against HCV-22E9. Saikosaponins inhibit viral attachment and penetration stages. The marketed drugs would be priced much higher than the actual manufacturing costs. Hence using these naturopathy and homeopathy medicines can restrain the market growth. Companies in the anti-viral drug therapy market are continuously innovating through technological advancements to develop drugs to treat different viral infections. Biopharmaceutical companies are developing vaccines for the treatment of novel coronavirus. Technological advances in the pharmaceutical sector include the development of nucleic acid vaccines that are DNA- and RNA-based, and which enable the human body to produce vaccine antigens. In March 2020, Applied DNA Sciences’ subsidiary LineaRx and Takis Biotech formed a joint venture to develop a linear DNA vaccine as a treatment for coronavirus. The JV will use Polymerase Chain Reaction (PCR)-based DNA manufacturing technology to develop the vaccine. Such initiatives and activities are projected to support market growth to a significant extent. In February 2020, GeoVax, a US-based pharmaceutical company, and BravoVax, a China-based pharmaceutical company, announced plans to develop a coronavirus cure in the form of a vaccine based on the former’s MVA-VLP vaccine platform. BravoVax will be responsible for testing and manufacturing the vaccine as well as coordinating with the public health and regulatory authorities in China. GeoVax’s Modified Vaccinia Ankara platform enables enhanced expression and stable transgenes during the manufacturing process. Combined with the immunogenicity of Virus-Like Particles (VLPs), the technology enables the production of vaccines. The collaboration between these two companies is to develop a coronavirus vaccine. Major players in the anti-viral drug therapy market are AbbVie Inc., Bristol-Myers-Squibb, Cipla, F. Hoffmann-La Roche Ltd., Gilead Sciences Inc., GlaxoSmithKline, Johnson & Johnson, Merck & Co., Inc., Dr. Reddy’s Laboratories Ltd., AstraZeneca PLC., Aurobindo Pharma, Abbott Laboratories, Schering-Plough Corporation, Pfizer Inc., Sanofi, Sanofi, Regeneron Pharmaceuticals, Inc., Inovio Pharmaceuticals, Inc., Novavax, Inc., and BioCryst Pharmaceuticals, Inc. North America was the largest region in the anti-viral drug therapy market in 2022. The Middle East is expected to be the fastest-growing region in the global antivirals market during the forecast period. The regions covered in the global anti-viral drug therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the anti-viral drug therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA. The anti-viral drug therapy market consists of sales of amantadine and rimantadine. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global antivirals market is segmented - 1) By Drug Class: DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors, Other Drug Classes 2) By Application: HIV, Hepatitis, Herpes, Influenza, and Other Applications 3) By Type: Branded, Generic

Polymerase Chain Reactions (PCR) devices and reagents are designed to aid scientists in producing multiple copies of specific DNA segments. In PCR, a section of the genome to be amplified is chosen using short synthetic DNA fragments called primers, and the segment is subsequently amplified through numerous rounds of DNA synthesis. The main products of Polymerase Chain Reactions (PCR) devices and reagents are instruments, reagents, and consumables. An instrument is a tool or device for doing a particular kind of work. The instruments used are standard PCR, rt- PCR, and digital PCR. The various end-users are the pharmaceutical and biotechnology industries, clinical diagnostics labs and hospitals, academics, and research organizations. The polymerase chain reactions (PCR) devices and reagents market research report is one of a series of new reports from The Business Research Company that provides polymerase chain reactions (PCR) devices and reagents market statistics, including polymerase chain reactions (PCR) devices and reagents industry global market size, regional shares, competitors with a polymerase chain reactions (PCR) devices and reagents market share, detailed polymerase chain reactions (PCR) devices and reagents market segments, market trends and opportunities, and any further data you may need to thrive in the polymerase chain reactions (PCR) devices and reagents industry. This polymerase chain reaction (PCR) devices and reagents market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global polymerase chain reactions (pcr) devices, reagents and uses market grew from $5.56 billion in 2022 to $5.9 billion in 2023 at a compound annual growth rate (CAGR) of 6.1%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The polymerase chain reactions (pcr) devices, reagents and uses market is expected to grow from $7.58 billion in 2027 at a CAGR of 6.5%. The growing prevalence of infectious diseases across the world is driving the polymerase chain reactions devices and reagents market. Polymerase chain reactions devices are used in clinical laboratories to detect the presence of infectious diseases. In a report published by the World Health Organization, it was reported that around 17 million people are killed in a year due to infectious diseases. Also, the same report stated that 30 new infectious diseases have emerged in the last 20 years. According to the National Centre for Health Statistics, 15.5 million people in the US visited a physician, due to an infectious disease. Such instances are increasing the demand for clinical diagnostic services and thereby driving the polymerase chain reactions devices and reagents market. The emergence of alternatives is a major restraint on the growth of polymerase chain reaction devices and the reagents market. In the field of DNA sequencing, the polymerase chain reaction technique has competitors like Next Generation Sequencing and Sanger Sequencing which provide similar utility as PCR devices and reagents and even better results in some cases, thus increasing the competition in the market and thereby limiting PCR devices and reagents growth. For instance, in a study conducted, 138 FFPE non-small lung cancer samples were examined, with assays developed through Sanger, Next Generation Sequencing, and polymerase chain reaction techniques. All three assays were compared and it was reported that assays developed by NGS and QPCR exhibited similar analytical sensitivity, simplicity, and high level of concordance. Moreover, it was found that NGS assays proved to be better than qPCR in displaying more accurate information about allele sequence, mutation frequency, and the detection of non-hotspot mutations. This emergence of alternative procedures is expected to restrain the growth of the market during the forecast period. Companies in the polymerase chain reaction devices and reagents market are increasingly focusing on Digital PCR due to its higher accuracy compared to conventional PCR. Conventional PCR is an end-point investigation that is not fully quantified because the enhanced item is distinguished by agarose gel electrophoresis. Digital PCR expands on customary PCR enhancement and fluorescent-probe– based identification techniques to give a comprehensive evaluation of nucleic acids without the requirement for standard bends. The companies investing in digital polymerase chain reaction technology include BioRad Technologies, Atlas Genetics, OriGene Technologies STST-Diagnostica, Ugen Tec, and Genesis Healthcare Company. Major players in the polymerase chain reactions (PCR) devices and reagents market are Bio-Rad Laboratories, F. Hoffmann-La Roche AG, Thermo Fisher Scientific, Becton, Dickinson and Company, Abbott, BioMérieux SA, Agilent Technologies, QIAGEN N.V., Siemens Healthcare GmbH (Siemens AG), and Fluidigm Corporation. North America was the largest region in the polymerase chain reactions (PCR) devices and reagents market in 2022. Western Europe was the second largest region in the global polymerase chain reactions (PCR) devices and reagents market report. The regions covered in the global polymerase chain reaction (PCR) devices and reagents market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the polymerase chain reactions (PCR) devices and reagents market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The polymerase chain reactions (PCR) devices and reagents market consists of sales of conventional PCR machines, qPCR, reverse transcription PCR, nested PCR, hot start PCR, and digital PCR devices. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organisations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the chain or as part of other products. The global polymerase chain reactions (PCR) devices, reagents and uses market is segmented - 1) By Product: Instruments, Reagents, Consumables 2) By End User: Pharmaceutical and biotechnoly industries, Clinical Diagnostics labs and hospitals, Academics and research organization 3) By Instruments: Standars PCR, RT-PCR, Digital PCR

Ethylene propylene is a type of synthetic rubber formed as a terpolymer of ethylene, propylene, and a diene component. It is resistant to heat and electricity and is non-reactive towards acids and alkali compounds. Ethylene propylene is used in weather-stripping and seals, glass-run channels, radiators, garden and appliance hoses, tubing, belts, and electrical insulation. The main product types of ethylene-propylene are solution polymerization and suspension polymerization. Solution polymerization is the polymerization that takes place in a solution. The presence of a solvent prevents the viscosity of the reaction mixture from becoming too high, which is beneficial for fluid flow and heat transfer. The various applications involved are automotive, building and construction, plastic modification, lubricant additives, wires and cables, and tires and tubes. The ethylene-propylene market research report is one of a series of new reports from The Business Research Company that provides ethylene-propylene market statistics, including ethylene-propylene industry global market size, regional shares, competitors with an ethylene-propylene market share, detailed ethylene-propylene market segments, market trends and opportunities, and any further data you may need to thrive in the ethylene-propylene industry. This ethylene-propylene market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global ethylene propylene (EPDM) market size will grow from $6.08 billion in 2022 to $6.69 billion in 2023 at a compound annual growth rate (CAGR) of 10.0%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global ethylene propylene (EPDM) market size is expected to grow from $9.45 billion in 2027 at a CAGR of 9.0%. The use of ethylene propylene across various industries contributes to the growth of the ethylene-propylene market. In the automotive industry, EPDM products bond well with metals by providing a well-built barrier against the environment. EPDM possesses properties such as heat resistance, abrasion resistance, oil swell resistance, flame retardance, oxidation, ozone, and weather ageing due to its stable, saturated polymer backbone structure. Companies such as BRP manufacturing are providing EPDM for the automotive industry that includes under-the-hood, cabin pressure-equalizing assemblies, interior trim, and striker plate blinds. Thus, the usage of EPDM in different industries is contributing to the EPDM market's growth. The release of volatile organic compounds (VOCs) while manufacturing ethylene-propylene causes environmental pollution, which is challenging the growth of the EPDM market. VOCs consist of different chemicals that show adverse effects on human health as well as on the environment as they release fine particulates into the atmosphere, resulting in the formation of smog and reduced visibility. For instance, to avoid harmful emissions of VOCs, the Hong Kong government has implemented various regulations, such as products exceeding normal emissions of VOCs are not allowed in the country. Thus, the increased release of VOCs from producing ethylene propylene is limiting its market growth. The increasing demand for ethylene propylene diene monomer (EPDM) rubber produced from bio-based feedstock acts as a key trend driving the growth of the EPDM market. Renewable EPDM rubber uses raw materials such as sugar and glycerin to replace traditional feedstock such as isoprene and butadiene in synthetic rubber production to reduce greenhouse emissions and to achieve sustainability. For instance, Keltan, a Netherlands-based company, produced the first commercial bio-based feedstock, KELTAN ECo., based on renewable raw materials. Therefore, renewable EPDM rubber is expected to increase the market share of the EPDM market. Major players in the ethylene-propylene market are The Dow Chemical Company, Exxon Mobil Corporation, Johns Manville, Inc., KUMHO POLYCHEM, Lanxess AG, Lion Elastomers LLC., Mitsui Chemicals, Inc., SK Global Chemical Co. Ltd., Sumitomo Chemical Co., Ltd., and Versalis S.p.A. Asia-Pacific was the largest region in the ethylene-propylene market in 2022. Middle East was the second-largest region in the global ethylene-propylene market. The regions covered in the global ethylene-propylene market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the ethylene-propylene market are Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, the UK, the USA, and Australia. The ethylene propylene market consists of the sales of ethylene propylene made with ethylene and propylene alone, and ethylene propylene made with small amounts of a diene (generally ethylidene norbornene or 1,4-hexadiene). Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global ethylene propylene (EPDM) market is segmented - 1) By Product Type: Solution Polymerization, Suspension Polymerization 2) By Application: Automotive, Building & Construction, Plastic Modification, Lubricant Additive, Wires & Cables, Tires & Tubes